marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
BridgeBio Pharma Financial Ratios 2011-2024 | BBIO
Annual Financial Ratios BridgeBio Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-8.3 | -3.6 | -1.9 | -16.5 | -14.1 | - | - | - | - | - | - | - | - |
P/S |
585.5 | 22.3 | 16.2 | 1011.0 | 90.5 | - | - | - | - | - | - | - | - |
EPS |
-4.0 | -3.3 | -3.9 | -3.8 | -2.5 | -2.1 | -1 | - | - | - | - | - | - |
EV (Enterprise Value) |
6.96 B | 3.22 B | 2.61 B | 8.58 B | 3.47 B | 130 M | 154 M | - | - | - | - | - | - |
EBITDA per Share |
-3.69 | -3.43 | -3.95 | -4.01 | -2.66 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-4.4 | -14.5 | -12.2 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.28 | 2.19 | - | - | - | - | - | - | - | - | ||
P/B |
-4.1 | -1.4 | -1.3 | 78.5 | 7.7 | - | - | - | - | - | - | - | - |
P/CF |
-10.3 | -4.1 | -2.3 | -20.9 | -14.2 | - | - | - | - | - | - | - | - |
ROE % |
48.24 | 38.63 | 67.64 | -475.73 | -55.01 | - | - | - | - | - | - | - | - |
ROA % |
-119.56 | -77.79 | -57.90 | -71.84 | -41.25 | - | - | - | - | - | - | - | - |
ROCE % |
44.85 | 40.83 | 66.51 | -446.55 | -46.60 | - | - | - | - | - | - | - | - |
Current Ratio |
0.3 | 0.3 | 0.5 | 1.2 | 9.4 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1657.3 | 1245.8 | 1220.7 | - | 1292.4 | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1657.3 | -1245.8 | -1220.7 | - | -1292.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios BridgeBio Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.86 | -0.39 | -0.2 | - | -1.08 | -0.98 | -0.92 | - | -0.93 | -0.07 | -1.35 | - | -1.06 | -0.66 | -1.18 | - | -0.98 | -1.03 | -0.78 | - | -0.51 | -0.71 | -0.66 | - | -0.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.01 | -0.93 | 0.01 | - | -0.96 | -0.91 | -0.82 | - | -0.87 | -0.54 | -1.18 | - | -0.99 | -0.64 | -1.2 | - | -1.01 | -1.05 | -0.87 | - | -0.47 | -0.75 | -0.69 | - | -0.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
38.73 | 40.39 | 45.39 | 38.69 | 51.11 | 48.52 | 36.87 | 32.02 | 53.81 | 63.18 | 84.91 | 87.06 | -137.73 | -384.32 | -641.53 | -639.77 | -654.62 | -444.68 | -227.65 | -50.05 | -63.41 | -61.93 | -43.73 | -13.36 | -13.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-65.87 | -68.57 | -90.97 | -82.12 | -101.36 | -93.19 | -86.05 | -68.76 | -89.36 | -65.96 | -75.40 | -45.69 | -64.19 | -62.09 | -72.01 | -52.65 | -62.26 | -53.36 | -45.77 | -32.36 | -41.41 | -40.86 | -29.09 | -9.05 | -9.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
44.81 | 42.42 | 37.18 | 34.41 | 45.86 | 44.11 | 41.20 | 36.04 | 56.27 | 65.06 | 77.40 | 82.86 | -124.27 | -351.63 | -587.00 | -599.23 | -612.59 | -418.81 | -220.66 | -45.93 | -59.10 | -58.91 | -41.94 | -13.17 | -13.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.3 | 0.4 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | - | 0.4 | 0.5 | 0.5 | 0.7 | 0.7 | 1.2 | 1.2 | 1.2 | 1.2 | 4.1 | 4.1 | 4.1 | 4.1 | 5.3 | 5.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | 23.6 | 1.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
2402.5 | 1743.7 | 1173.7 | - | 636.8 | 605.5 | 1095.7 | - | 627.1 | 658.8 | - | - | 1078.3 | 13674.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | 23.6 | 1.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-2402.5 | -1743.7 | -1173.7 | - | -636.8 | -605.5 | -1095.7 | - | -627.1 | -658.8 | - | - | -1054.7 | -13673.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency